Robert C. Bourge

24.4k total citations · 8 hit papers
230 papers, 16.4k citations indexed

About

Robert C. Bourge is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Robert C. Bourge has authored 230 papers receiving a total of 16.4k indexed citations (citations by other indexed papers that have themselves been cited), including 139 papers in Cardiology and Cardiovascular Medicine, 113 papers in Surgery and 56 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Robert C. Bourge's work include Transplantation: Methods and Outcomes (79 papers), Heart Failure Treatment and Management (67 papers) and Pulmonary Hypertension Research and Treatments (48 papers). Robert C. Bourge is often cited by papers focused on Transplantation: Methods and Outcomes (79 papers), Heart Failure Treatment and Management (67 papers) and Pulmonary Hypertension Research and Treatments (48 papers). Robert C. Bourge collaborates with scholars based in United States, United Kingdom and Canada. Robert C. Bourge's co-authors include William T. Abraham, James K. Kirklin, Lynne W. Stevenson, Philip B. Adamson, Maria Rosa Costanzo, David C. Naftel, Robyn J. Barst, Lewis J. Rubin, Stuart Rich and James W. Crow and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Robert C. Bourge

225 papers receiving 15.8k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension

1996 2.0k citations Robyn J. Barst, Lewis J. Rubin et al. profile →
Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial

2011 1.1k citations William T. Abraham, Robert C. Bourge et al. profile →
Continuous Subcutaneous Infusion of Treprostinil, a Prostacyclin Analogue, in Patients with Pulmonary Arterial Hypertension: A Double-blind, Randomized, Placebo-controlled Trial

2002 1.1k citations Gérald Simonneau, Robyn J. Barst et al. American Journal of Respiratory and Critical Care Medicine profile →
Intravenous Nesiritide, a Natriuretic Peptide, in the Treatment of Decompensated Congestive Heart Failure

2000 669 citations Wilson S. Colucci, William T. Abraham et al. profile →
Imatinib Mesylate as Add-on Therapy for Pulmonary Arterial Hypertension

2013 411 citations Marius M. Hoeper, Robyn J. Barst et al. Circulation profile →
Randomized Controlled Trial of an Implantable Continuous Hemodynamic Monitor in Patients With Advanced Heart Failure

2008 403 citations Robert C. Bourge, William T. Abraham et al. Journal of the American College of Cardiology profile →
Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial

2015 393 citations William T. Abraham, Robert C. Bourge et al. profile →
Wireless Pulmonary Artery Pressure Monitoring Guides Management to Reduce Decompensation in Heart Failure With Preserved Ejection Fraction

2014 303 citations William T. Abraham, Robert C. Bourge et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert C. Bourge United States	59	10.9k	5.7k	5.4k	2.7k	1.6k	230	16.4k
Anne Keogh Australia	55	6.5k 0.6×	6.9k 1.2×	4.4k 0.8×	1.3k 0.5×	1.7k 1.0×	273	13.7k
Barry F. Uretsky United States	54	10.6k 1.0×	4.9k 0.9×	5.9k 1.1×	1.1k 0.4×	290 0.2×	283	15.3k
Sharon A. Hunt United States	47	11.6k 1.1×	4.8k 0.8×	7.1k 1.3×	2.4k 0.9×	1.4k 0.8×	140	18.2k
Stephen C. Textor United States	66	5.0k 0.5×	6.6k 1.2×	5.2k 1.0×	786 0.3×	2.0k 1.2×	282	17.7k
Richard J. Rodeheffer United States	68	18.1k 1.7×	3.0k 0.5×	3.7k 0.7×	1.6k 0.6×	576 0.4×	198	23.8k
Alan C. Yeung United States	55	8.3k 0.8×	2.2k 0.4×	7.6k 1.4×	1.2k 0.5×	492 0.3×	294	14.6k
Michael M. Givertz United States	52	10.5k 1.0×	2.4k 0.4×	3.6k 0.7×	2.3k 0.9×	363 0.2×	180	14.8k
Steven M. Kawut United States	61	4.6k 0.4×	9.4k 1.6×	3.4k 0.6×	711 0.3×	425 0.3×	290	13.3k
Marc J. Semigran United States	56	7.5k 0.7×	3.3k 0.6×	2.6k 0.5×	1.4k 0.5×	334 0.2×	164	11.7k
JoAnn Lindenfeld United States	53	11.5k 1.1×	1.8k 0.3×	4.0k 0.7×	1.8k 0.7×	439 0.3×	347	15.8k

Countries citing papers authored by Robert C. Bourge

Since Specialization

Citations

This map shows the geographic impact of Robert C. Bourge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert C. Bourge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert C. Bourge more than expected).

Fields of papers citing papers by Robert C. Bourge

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert C. Bourge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert C. Bourge. The network helps show where Robert C. Bourge may publish in the future.

Co-authorship network of co-authors of Robert C. Bourge

This figure shows the co-authorship network connecting the top 25 collaborators of Robert C. Bourge. A scholar is included among the top collaborators of Robert C. Bourge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert C. Bourge. Robert C. Bourge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cotter, Gad, Marco Metra, Beth A. Davison, et al.. (2017). Systolic Blood Pressure Reduction During the First 24 H in Acute Heart Failure Admission: Friend or Foe?. European Journal of Heart Failure. 20(2). 317–322. 17 indexed citations

Cleland, John G.F., John R. Teerlink, Beth A. Davison, et al.. (2017). Measurement of Troponin and Natriuretic Peptides Shortly After Admission in Patients with Heart Failure—Does it Add Useful Prognostic Information? an Analysis of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute Heart Failure Studies (VERITAS). European Journal of Heart Failure. 19(6). 739–747. 24 indexed citations

Cotter, Gad, Marco Metra, Beth A. Davison, et al.. (2014). Worsening Heart Failure, a Critical Event During Hospital Admission for Acute Heart Failure: Results from the VERITAS Study. European Journal of Heart Failure. 16(12). 1362–1371. 23 indexed citations

Hoeper, Marius M., Robyn J. Barst, Robert C. Bourge, et al.. (2013). Imatinib Mesylate as Add-on Therapy for Pulmonary Arterial Hypertension. Circulation. 127(10). 1128–1138. 411 indexed citations breakdown →

Bourge, Robert C., Victor F. Tapson, Zeenat Safdar, et al.. (2012). Rapid Transition from Inhaled Iloprost to Inhaled Treprostinil in Patients with Pulmonary Arterial Hypertension. Cardiovascular Therapeutics. 31(1). 38–44. 29 indexed citations

Zhang, Yan, Robert C. Bourge, Meredith L. Kilgore, et al.. (2011). Abstract 12064: Low Income, Regardless of Education Level, is a Significant Independent Predictor of Incident Heart Failure in Community-Dwelling, Medicare-Eligible Older Adults. Circulation. 124. 1 indexed citations

Tallaj, José, Ish Singla, & Robert C. Bourge. (2009). Implantable Hemodynamic Monitors. Heart Failure Clinics. 5(2). 261–270. 1 indexed citations

Frantz, Robert P., Raymond L. Benza, Barbro Kjellström, et al.. (2008). Continuous Hemodynamic Monitoring in Patients With Pulmonary Arterial Hypertension. The Journal of Heart and Lung Transplantation. 27(7). 780–788. 23 indexed citations

Butler, Javed, James B. Young, William T. Abraham, et al.. (2006). Beta-Blocker Use and Outcomes Among Hospitalized Heart Failure Patients. Journal of the American College of Cardiology. 47(12). 2462–2469. 72 indexed citations

10.

Zoghbi, Gilbert J., Vijay K. Misra, Gregory D. Chapman, et al.. (2004). Long‐term follow‐up of brachytherapy for treatment of allograft in‐stent restenosis. Catheterization and Cardiovascular Interventions. 61(2). 217–221. 1 indexed citations

11.

McLaughlin, Vallerie V., Seán Gaine, Robyn J. Barst, et al.. (2003). Efficacy and Safety of Treprostinil: An Epoprostenol Analog for Primary Pulmonary Hypertension. Journal of Cardiovascular Pharmacology. 41(2). 293–299. 176 indexed citations

12.

Simonneau, Gérald, Robyn J. Barst, Nazzareno Galiè, et al.. (2002). Continuous Subcutaneous Infusion of Treprostinil, a Prostacyclin Analogue, in Patients with Pulmonary Arterial Hypertension: A Double-blind, Randomized, Placebo-controlled Trial. American Journal of Respiratory and Critical Care Medicine. 165(6). 800–804. 1052 indexed citations breakdown →

13.

Kirklin, James K., Robert C. Bourge, David C. Naftel, & David C. McGiffin. (2002). Is there a need for surveillance endomyocardial biopsies inheart transplantation?. Transplantation Proceedings. 34(5). 1857–1859. 8 indexed citations

14.

Cohn, Jay N., Sidney Goldstein, Barry Greenberg, et al.. (1999). A Dose-Dependent Increase in Mortality with Vesnarinone Among Patients with Severe Heart Failure. Survey of Anesthesiology. 43(5). 257–258. 31 indexed citations

15.

LeJemtel, Thierry H., et al.. (1998). Recombinant human B-type natriuretic peptide improves symptoms and hemodynamics in patients with acutely decompensated CHF. Journal of the American College of Cardiology. 31. 83–83. 6 indexed citations

16.

Holman, William L., et al.. (1995). Left Atrial or Ventricular Cannulation Beyond 30 Days for a Thoratec Ventricular Assist Device. ASAIO Journal. 41(3). M517–M522. 18 indexed citations

17.

Kirklin, James K., William M. Novick, David C. Naftel, et al.. (1993). Long-term function of cryopreserved aortic homografts. Journal of Thoracic and Cardiovascular Surgery. 106(1). 154–166. 177 indexed citations

18.

Kobashigawa, Jon, James K. Kirklin, David C. Naftel, et al.. (1993). Pretransplantation risk factors for acute rejection after heart transplantation: A multiinstitutional study. The Journal of Heart and Lung Transplantation. 12(3). 355–366. 71 indexed citations

19.

Henzlova, Milena J., et al.. (1991). Long-term effect of thrombolytic therapy on left ventricular ejection fraction after acute myocardial infarction. The American Journal of Cardiology. 67(16). 1354–1359. 8 indexed citations

20.

Rogers, William J., Robert C. Bourge, Silvio E. Papapietro, et al.. (1989). Variables predictive of good functional outcome following thrombolytic therapy in the Thrombolysis in Myocardial Infarction phase II (TIMI II) pilot study. The American Journal of Cardiology. 63(9). 503–512. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact